Editorial

The Tamiflu saga continues: will our conduct change after the publication of the latest systematic review on benefits and harms of oseltamivir?

Back to article
Results of trials with Oseltamivir intervention for symptomatic Influenza. Adapted from Tom Jefferson, et al. [2]